tradmap

GRDN Guardian Pharmacy Services, Inc.

$40.90 +2.29%

Data as of close

Consumer Defensive · Retail-Drug Stores And Proprietary Stores

Guardian Pharmacy Services, Inc. (GRDN) is a consumer defensive company in the Retail-Drug Stores And Proprietary Stores industry, with a market capitalization of $2.6 billion. Shares last traded at $40.90, 17.4% below their 52-week high. Over the past year the stock is up 45.6%. GRDN trades at a price-to-earnings ratio of 39.30, above the Retail-Drug Stores And Proprietary Stores median of 31.64. Net profit margin is 4.5%, above the peer median of -0.2%. Revenue grew 17.9% year over year.

Market Cap
$2.6B
Shares Out
63.3M
EPS (TTM)
$1.04
P/E (TTM)*
39.30
P/S Ratio
1.77
P/B Ratio
10.05
Dividend / Share
—
Dividend Yield
—
52-Week High
$49.51
52-Week Low
$26.64
Volume (venue)
76,536
Avg Vol (3m, venue)
30,386.889

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
+3.19%
1M
-2.95%
3M
+0.90%
6M
+9.79%
YTD
+36.14%
1Y
+45.61%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
51.72
SMA (50)
$41.17
SMA (200)
$38.20
Price vs SMA50
-0.67%
Price vs SMA200
+7.05%
ATR (14)
$1.87

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$1.5B
Net Income
$66M
Gross Margin
21.6%
Operating Margin
5.8%
Net Margin
4.5%
Return on Equity
25.6%
Return on Assets
14.9%
Current Ratio
1.65
Debt / Equity
0.00
Revenue Growth (YoY)
+17.9%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $0.34 2026-08-06
Q1 2026 $0.21 2026-05-06
Q4 2025 (derived) $0.34 2026-03-11
FY 2025 $0.78 2026-03-11
Q3 2025 $0.15 2025-11-10
Q2 2025 $0.14 2025-08-11

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Retail-Drug Stores And Proprietary Stores peers

GRDN vs 5 industry peers (Retail-Drug Stores And Proprietary Stores), by market cap. Data as of close

P/E vs peers
39.30 / 31.64 med
+24% premium
P/S vs peers
1.77 / 0.57 med
+211% premium
Net margin vs peers
4.5% / -0.2% med
above median
1–5 of 5
CVSCVS Health$117.3B23.980.281.2%+3.59%
GRDNGuardian Pharmacy Services, Inc.$2.6B39.301.774.5%+2.29%
RDGTRidgetech Inc.$113M—0.86-0.9%+2.41%
PETSPETMED EXPRESS INC$26M—0.15-17.3%-0.42%
YI111, Inc.———-0.2%+0.66%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.